QUIA PHARMA
0,024 SEK -2,46%Vær den første som følger denne virksomhed
QUIA PHARMA operates in medical technology. The company has developed a technological platform that is used to develop existing pharmaceuticals. The technology is based on what is known as PEGylation, a technique that connects water-soluble polymers with the pharmaceuticals and is used to improve various characteristics in the biopharmaceuticals in regards to stability and resistance.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
QUIA
Daglig lav / høj pris
0,023 / 0,024
SEK
Markedsværdi
35,46 mio. SEK
Aktieomsætning
35,12 t SEK
Volumen
1,5 mio.
Finanskalender
Årsrapport
26.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Iskander World AB | 10,7 % | 10,7 % |
Nordnet Pensionsförsäkring AB | 4,3 % | 4,3 % |
Avanza Pension | 2,7 % | 2,7 % |
Jasmina Nezirovic | 2,2 % | 2,2 % |
Markus Svensson | 1,6 % | 1,6 % |
Viktor Eriksson | 1,4 % | 1,4 % |
Teddie Hansson | 1,3 % | 1,3 % |
Tony Chouha | 1,3 % | 1,3 % |
Driton Mehmedi | 1,2 % | 1,2 % |
ViserAlle indholdstyper
QuiaPEG has submitted a formal application to Nasdaq for the reverse acquisition of Rosemonkey Ltd.
QuiaPEG och Net Zero Infrastucture take next step to a formal license agreement
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools